BioElectronics Corp
OTC:BIEL
Balance Sheet
Balance Sheet Decomposition
BioElectronics Corp
BioElectronics Corp
Balance Sheet
BioElectronics Corp
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+570%
|
1
-43%
|
0
-39%
|
0
-51%
|
1
+452%
|
1
+7%
|
1
-18%
|
1
-12%
|
1
-10%
|
1
-22%
|
1
+45%
|
1
-29%
|
1
-5%
|
0
-31%
|
0
-26%
|
0
+23%
|
0
-80%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
2
|
2
|
2
|
3
|
5
|
5
|
5
|
7
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
6
|
4
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Total Current Liabilities |
1
|
1
|
2
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
6
|
6
|
6
|
9
|
9
|
9
|
6
|
|
| Long-Term Debt |
0
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
6
|
6
|
4
|
5
|
6
|
5
|
6
|
7
|
9
|
|
| Total Liabilities |
1
N/A
|
2
+72%
|
3
+67%
|
3
+0%
|
3
+10%
|
2
-25%
|
5
+119%
|
6
+26%
|
7
+15%
|
8
+21%
|
9
+5%
|
10
+11%
|
10
+6%
|
11
+8%
|
13
+19%
|
15
+11%
|
16
+4%
|
15
-2%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
4
|
6
|
11
|
15
|
19
|
21
|
23
|
23
|
23
|
|
| Retained Earnings |
1
|
3
|
6
|
8
|
10
|
12
|
15
|
18
|
20
|
22
|
25
|
28
|
30
|
32
|
35
|
37
|
38
|
38
|
|
| Additional Paid In Capital |
1
|
3
|
4
|
6
|
7
|
9
|
10
|
11
|
11
|
11
|
11
|
8
|
5
|
2
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
+64%
|
2
-631%
|
2
-16%
|
3
-24%
|
1
+65%
|
4
-268%
|
5
-42%
|
6
-20%
|
8
-26%
|
8
-8%
|
9
-9%
|
10
-10%
|
11
-9%
|
13
-23%
|
15
-12%
|
15
-4%
|
15
+0%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+570%
|
1
-43%
|
0
-39%
|
0
-53%
|
1
+477%
|
1
+7%
|
1
-18%
|
1
-12%
|
1
-10%
|
1
-22%
|
1
+45%
|
1
-29%
|
1
-5%
|
0
-31%
|
0
-26%
|
0
+23%
|
0
-80%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
51
|
63
|
76
|
118
|
267
|
1 471
|
1 547
|
1 951
|
2 666
|
3 860
|
6 409
|
10 714
|
14 966
|
18 992
|
20 706
|
22 918
|
24 135
|
24 379
|
|